American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Becton Dickinson
BDX
|
+$389M |
| 2 |
Meta Platforms (Facebook)
META
|
+$296M |
| 3 |
Salesforce
CRM
|
+$207M |
| 4 |
Howmet Aerospace
HWM
|
+$122M |
| 5 |
Reinsurance Group of America
RGA
|
+$121M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$349M |
| 2 |
Visa
V
|
+$249M |
| 3 |
IQVIA
IQV
|
+$234M |
| 4 |
T-Mobile US
TMUS
|
+$226M |
| 5 |
NXP Semiconductors
NXPI
|
+$212M |
Sector Composition
| 1 | Technology | 23.35% |
| 2 | Healthcare | 13.84% |
| 3 | Financials | 13.36% |
| 4 | Consumer Discretionary | 11.5% |
| 5 | Industrials | 10.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Cue Biopharma
CUE
$58.8M
| $44K | ﹤0.01% |
+12,045
| New | +$44K |
|
2677
Oramed Pharmaceuticals
ORMP
$99.6M
| $42.2K | ﹤0.01% |
+11,789
| New | +$42.2K |
|
2678
Adicet Bio
ACET
$73.4M
| $41.2K | ﹤0.01% |
16,943
+6,723
| +66% | +$16.3K |
|
|
NGM
2679
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $40.8K | ﹤0.01% |
+15,738
| New | +$40.8K |
|
2680
Latham Group
SWIM
$929M
| $40.7K | ﹤0.01% |
+10,982
| New | +$40.7K |
|
2681
Altimmune
ALT
$326M
| $39.4K | ﹤0.01% |
+11,171
| New | +$39.4K |
|
|
ATYR
2682
aTyr Pharma
ATYR
$515M
| $30.7K | ﹤0.01% |
+14,191
| New | +$30.7K |
|
2683
Nkarta
NKTX
$147M
| $29.9K | ﹤0.01% |
+13,640
| New | +$29.9K |
|
2684
Telos
TLS
$505M
| $28.5K | ﹤0.01% |
+11,149
| New | +$28.5K |
|
|
AGEN
2685
Agenus
AGEN
$151M
| $27.3K | ﹤0.01% |
853
-16
| -2% | -$512 |
|
2686
Arbutus Biopharma
ABUS
$939M
| $24.5K | ﹤0.01% |
+10,660
| New | +$24.5K |
|
2687
Atara Biotherapeutics
ATRA
$85.4M
| $23.6K | ﹤0.01% |
585
-320
| -35% | -$12.9K |
|
|
GAU
2688
Galiano Gold
GAU
$644M
| $22.9K | ﹤0.01% |
37,966
| – | – |
|
2689
Gannett
GCI
$632M
| $22.8K | ﹤0.01% |
+10,153
| New | +$22.8K |
|
|
TSP
2690
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $22.2K | ﹤0.01% |
13,350
-666
| -5% | -$1.11K |
|
|
PSTX
2691
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $22K | ﹤0.01% |
12,477
+22
| +0.2% | +$39 |
|
2692
Co-Diagnostics
CODX
$13.3M
| $12.6K | ﹤0.01% |
11,393
-209,806
| -95% | -$233K |
|
|
CANG
2693
Cango
CANG
$476M
| $11.9K | ﹤0.01% |
10,190
| – | – |
|
|
AEVA
2694
Aeva Technologies
AEVA
$893M
| – | – |
-4,188
| Closed | -$23.5K |
|
2695
Acadia Realty Trust
AKR
$2.59B
| – | – |
-19,449
| Closed | -$271K |
|
|
ALLK
2696
DELISTED
Allakos
ALLK
| – | – |
-20,106
| Closed | -$86.5K |
|
2697
Ardelyx
ARDX
$1.61B
| – | – |
-15,475
| Closed | -$71K |
|
2698
Algoma Steel
ASTL
$484M
| – | – |
-228,692
| Closed | -$1.76M |
|
2699
Black Hills Corp
BKH
$4.33B
| – | – |
-112,071
| Closed | -$7.07M |
|
2700
Barnes & Noble Education
BNED
$289M
| – | – |
-198
| Closed | -$30.6K |
|